Literature DB >> 28859183

Association Between Patient Value Systems and Physician and Practice Attributes Available Online.

Jamie L Welshhans1, Jeffrey J Harmon1, Ira Papel2, Richard Gentile3, Devinder Mangat4, Patrick Byrne5, Ryan M Collar6.   

Abstract

IMPORTANCE: The relative value of facial plastic surgeon personal and practice attributes is relevant to the broader health care system because of increasing out-of-pocket expenses to patients.
OBJECTIVE: To determine the relative value of specific facial plastic surgeon personal and practice attributes available online from the perspective of patients. DESIGN, SETTING, AND PARTICIPANTS: This study consisted of an electronic survey sent to patients by email using choice-based conjoint analysis; surveys were sent between December 2015 and March 2016. Participants had agreed to join email registries to be sent email surveys and promotions at 3 private facial plastic and reconstructive surgery practices. The following surgeon personal and practice attributes and levels were compared: (1) outcome transparency (above average, average, not available); (2) surgical training affiliations (US News and World Reports rankings); (3) online rating site scores (2 [poor], 3, or 4 [excellent] stars); and (4) price ($1×, $2×, and $3× [× = $1500; average cost was set at $2×]). MAIN OUTCOMES AND MEASURES: The relative importance of outcome transparency, surgical training affiliations, online rating scores, and price to prospective patients.
RESULTS: Overall, 291 patients participated for a completion rate of 68%. Outcome transparency was the most valued attribute (attribute utility range = 141; attribute importance = 35.2%). Price was the least valued attribute (attribute utility range = 58.59; attribute importance = 15.1%). Assuming top-tier affiliations and 4-star ratings, share of market (SOM) was 75.5% for surgeons with above-average outcome transparency priced at $3× compared with those surgeons with no outcomes available priced at $1×. Holding price constant at $2×, surgeons with middle-tier affiliations and 2-star online ratings but above average outcomes achieved 48.4% SOM when compared with those surgeons with top-tier affiliations and 4-star online ratings without available outcomes. CONCLUSIONS AND RELEVANCE: Facial plastic surgery patients most value surgeons who publish outcomes. Moreover, they are willing to discount poor rating scores and lower-ranked institutional affiliations when outcome transparency is high. This study demonstrates that outcome transparency is crucial in facial plastic surgery markets. LEVEL OF EVIDENCE: NA.

Entities:  

Mesh:

Year:  2018        PMID: 28859183      PMCID: PMC5885961          DOI: 10.1001/jamafacial.2017.1146

Source DB:  PubMed          Journal:  JAMA Facial Plast Surg        ISSN: 2168-6076            Impact factor:   4.611


  14 in total

1.  Conjoint Analysis Applications in Health - How are Studies being Designed and Reported?: An Update on Current Practice in the Published Literature between 2005 and 2008.

Authors:  Deborah Marshall; John F P Bridges; Brett Hauber; Ruthanne Cameron; Lauren Donnalley; Ken Fyie; F Reed Johnson
Journal:  Patient       Date:  2010-12-01       Impact factor: 3.883

2.  Physician preferences for bone metastasis drug therapy in Canada.

Authors:  J Arellano; J M González; Y Qian; M Habib; A F Mohamed; F Gatta; A B Hauber; J Posner; N Califaretti; E Chow
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

3.  Views of glaucoma patients on aspects of their treatment: an assessment of patient preference by conjoint analysis.

Authors:  Jonathan S Bhargava; Bakula Patel; Alexander J E Foss; Anthony J Avery; Anthony J King
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

4.  What patients look for when choosing a plastic surgeon: an assessment of patient preference by conjoint analysis.

Authors:  Joshua T Waltzman; Thomas Scholz; Gregory R D Evans
Journal:  Ann Plast Surg       Date:  2011-06       Impact factor: 1.539

5.  Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force.

Authors:  John F P Bridges; A Brett Hauber; Deborah Marshall; Andrew Lloyd; Lisa A Prosser; Dean A Regier; F Reed Johnson; Josephine Mauskopf
Journal:  Value Health       Date:  2011-04-22       Impact factor: 5.725

6.  Physicians' preferences for bone metastases drug therapy in the United States.

Authors:  Jorge Arellano; A Brett Hauber; Ateesha F Mohamed; Juan Marcos Gonzalez; Helen Collins; Guy Hechmati; Francesca Gatta; Yi Qian
Journal:  Value Health       Date:  2015-01       Impact factor: 5.725

7.  Vietnamese Health Care Providers' Preferences Regarding Recommendation of HPV Vaccines.

Authors:  Gladys B Asiedu; Carmen Radecki Breitkopf; Walter K Kremers; Quang V Ngo; Nguyen V Nguyen; Benjamin J Barenberg; Vinh D Tran; Tri A Dinh
Journal:  Asian Pac J Cancer Prev       Date:  2015

8.  What Do Our Patients Truly Want? Conjoint Analysis of an Aesthetic Plastic Surgery Practice Using Internet Crowdsourcing.

Authors:  Cindy Wu; C Scott Hultman; Paul Diegidio; Steven Hermiz; Roja Garimella; Trisha M Crutchfield; Clara N Lee
Journal:  Aesthet Surg J       Date:  2016-09-20       Impact factor: 4.283

9.  Use of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effects.

Authors:  Kathleen Beusterien; Jessica Grinspan; Iryna Kuchuk; Sasha Mazzarello; Susan Dent; Stan Gertler; Nathaniel Bouganim; Lisa Vandermeer; Mark Clemons
Journal:  Oncologist       Date:  2014-01-28

10.  The best marketing strategy in aesthetic plastic surgery: evaluating patients' preferences by conjoint analysis.

Authors:  Nick Marsidi; Maurice W H M van den Bergh; Roland W Luijendijk
Journal:  Plast Reconstr Surg       Date:  2014-01       Impact factor: 4.730

View more
  1 in total

1.  Job satisfaction and its related factors among emergency department physicians in China.

Authors:  Kang Li; Hongmei Chen; Zhen Tan; Xiaoxv Yin; Yanhong Gong; Nan Jiang; Fengjie Yang
Journal:  Front Public Health       Date:  2022-07-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.